AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Why Venus Concept Shares Are Trading Higher By Over 200%; Here Are 20 Stocks Moving Premarket

BenzingaApr 9 04:58 ET

Incannex Healthcare Completes Phase 2 Enrollment in RePOSA Phase 2/3 Trial of IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA)

GlobeNewswireApr 3 07:30 ET

Express News | Incannex Healthcare Completes Phase 2 Enrollment in Reposa Phase 2/3 Trial of Ihl-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (Osa)

ReutersApr 3 07:30 ET

Incannex Healthcare Files Registration Statement for Sale of Shares

MT NewswiresMar 24 17:56 ET

Incannex Healthcare Repays Convertible Debenture in Full

TipRanksMar 18 06:31 ET